We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

64 hedge funds and large institutions have $123M invested in ChemoCentryx, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

559% more call options, than puts

Call options by funds: $455K | Put options by funds: $69K

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 6664 (-2)

21% less capital invested

Capital invested by funds: $155M → $123M (-$32.5M)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
64
Holders Change
-2
Holders Change %
-3.03%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
20
Reduced
19
Closed
8
Calls
$455K
Puts
$69K
Net Calls
+$386K
Net Calls Change
+$330K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$307K +$70.8K +13,400 +24%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$283K
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$226K +$1.52K +287 +0.6%
BBA
29
Baker Bros. Advisors
New York
$225K
TAM
30
Tocqueville Asset Management
New York
$225K
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$202K +$19.4K +3,668 +9%
KeyBank National Association
32
KeyBank National Association
Ohio
$173K -$90.4K -17,099 -31%
PPA
33
Parametric Portfolio Associates
Washington
$164K -$94.3K -17,846 -33%
Charles Schwab
34
Charles Schwab
California
$158K -$86.4K -16,339 -32%
TA
35
Teachers Advisors
New York
$153K
ProShare Advisors
36
ProShare Advisors
Maryland
$149K -$33.6K -6,360 -16%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$147K
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$121K +$65K +12,298 +85%
Millennium Management
39
Millennium Management
New York
$119K +$140K +26,403 New
DekaBank Deutsche Girozentrale
40
DekaBank Deutsche Girozentrale
Germany
$115K +$2.64K +500 +2%
CS
41
Credit Suisse
Switzerland
$96K +$4.37K +826 +4%
NFA
42
Nationwide Fund Advisors
Ohio
$94K +$2.07K +391 +2%
Barclays
43
Barclays
United Kingdom
$94K +$11K +2,074 +10%
SG Americas Securities
44
SG Americas Securities
New York
$90K +$106K +20,102 New
Deutsche Bank
45
Deutsche Bank
Germany
$89K -$237K -44,855 -69%
AIG
46
American International Group
New York
$80.5K -$63 -12 -0.1%
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$64K
Group One Trading
48
Group One Trading
Illinois
$56K +$32.5K +6,150 +98%
BA
49
BlackRock Advisors
Delaware
$52K
BGA
50
Belmont Global Advisors
Texas
$45K -$52.9K -10,000 -50%

CCXI Hedge Fund Activity: Q3 2014 in Review

64 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2014, worth a combined $123M — down 21% from $155M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CCXI and 6 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 20 added.

The largest buyer was Great Point Partners, opening a new position worth an estimated $2.56M. The largest seller was Broadfin Capital, cutting an estimated $1.32M.

  • 64 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2014, down from 66 in Q2 2014.
  • Funds reported $123M of ChemoCentryx, Inc. stock for Q3 2014, down 21% quarter-over-quarter.
  • 6 funds opened new ChemoCentryx, Inc. positions in Q3 2014 and 8 closed out, a net change of -2 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2014 was Great Point Partners, an estimated $2.56M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $1.32M sold.

Based on aggregated 13F filings for Q3 2014.